Erste Group Bank Issues Optimistic Forecast for UNH Earnings

Key Points

• Erste Group Bank raised its FY2027 EPS forecast for UnitedHealth to $22.51 from $22.45, while maintaining a “Hold” rating. The estimate remains above the current full-year consensus of $19.85 per share.
• UnitedHealth’s latest quarterly results exceeded expectations, with EPS of $6.38 versus the $4.94 consensus and revenue of $112.03 billion versus $110.81 billion expected. Management’s FY2026 EPS guidance is $19.50–$20.00.
• Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and an average price target of $456.56; the company also offers a $2.32 quarterly dividend, equivalent to a roughly 2.5% yield.

UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Analysts at Erste Group Bank raised their FY2027 earnings per share (EPS) estimates for shares of UnitedHealth Group in a research report issued on Friday, September 18th. Erste Group Bank analyst H. Engel now forecasts that the healthcare conglomerate will earn $22.51 per share for the year, up from their prior estimate of $22.45. Erste Group Bank has a "Hold" rating on the stock. The consensus estimate for UnitedHealth Group's current full-year earnings is $19.85 per share.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business's revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS.

Several other brokerages also recently issued reports on UNH. Cantor Fitzgerald reissued an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a report on Monday, July 13th. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. TD Cowen upped their price objective on UnitedHealth Group from $337.00 to $430.00 and gave the stock a "hold" rating in a report on Tuesday, July 14th. Finally, Morgan Stanley lifted their target price on UnitedHealth Group from $468.00 to $529.00 and gave the company an "overweight" rating in a report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $456.56.

UnitedHealth Group Price Performance

NYSE:UNH opened at $377.06 on Monday. The firm has a market cap of $338.45 billion, a price-to-earnings ratio of 24.26, a price-to-earnings-growth ratio of 1.42 and a beta of 0.61. UnitedHealth Group has a 12-month low of $255.96 and a 12-month high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The company's 50-day moving average is $403.75 and its two-hundred day moving average is $371.51.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is 59.72%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. BlackRock Inc. lifted its holdings in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% during the fourth quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate's stock worth $14,931,592,000 after acquiring an additional 1,119,834 shares during the last quarter. Capital World Investors boosted its holdings in UnitedHealth Group by 3.8% in the fourth quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate's stock valued at $7,457,723,000 after purchasing an additional 824,120 shares during the last quarter. Capital International Investors raised its position in shares of UnitedHealth Group by 6.6% in the 4th quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate's stock valued at $6,158,734,000 after purchasing an additional 1,155,162 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock worth $4,449,317,000 after buying an additional 616,723 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Value appeal: Zacks identifies UnitedHealth as a potentially attractive long-term value stock, supported by its scale, earnings potential and relatively reasonable valuation. The company’s current full-year 2026 adjusted EPS guidance of $19.50–$20.00 also provides an earnings framework for investors. Why UnitedHealth Group is a Top Value Stock for the Long-Term
• Positive Sentiment: Constructive analyst view: Brokerage recommendations point to a consensus “Moderate Buy,” while separate coverage highlights optimistic Wall Street sentiment. Although analyst ratings are not always reliable predictors, the consensus can help support demand for the shares. UnitedHealth Given Consensus Recommendation of Moderate Buy
• Positive Sentiment: Defensive and dividend characteristics: UnitedHealth is featured among large-cap healthcare stocks viewed as relatively attractive in a higher-rate environment because of recurring cash flows, balance-sheet scale and dividend income. Its annualized dividend is approximately $9.28 per share, with a yield above 2.4%. This Dividend Stock Is Staging a Turnaround in 2026
• Neutral Sentiment: Employer cost trends are mixed: Surging projected employer healthcare costs could increase demand for individual coverage products, potentially benefiting insurers. At the same time, higher medical expenses may pressure insurers’ margins, making the effect on UNH uncertain. Employer Health Costs Surge
• Negative Sentiment: Lower Q4 EPS forecast: An analyst reduced the fourth-quarter earnings-per-share forecast, signaling near-term caution about UnitedHealth’s profitability and creating a counterweight to the broader bullish analyst consensus. Q4 EPS Forecast for UnitedHealth Decreased

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.